tris(4-tert-butyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine);3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+))

C67H69F9N24Pt3 — CID 157146122

IUPACtris(4-tert-butyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine);3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+))
SMILESCC(C)(C)c1ccnc(-c2nc(C(F)(F)F)n[n-]2)c1.CC(C)(C)c1ccnc(-c2nc(C(F)(F)F)n[n-]2)c1.CC(C)(C)c1ccnc(-c2nc(C(F)(F)F)n[n-]2)c1.Cc1cc(-c2nccn2-c2ccccc2)[n-]n1.Cc1cc(-c2nccn2C(C)C)[n-]n1.Cc1cc(-c2nccn2C)[n-]n1.[Pt+2].[Pt+2].[Pt+2]
InChIInChI=1S/C13H11N4.3C12H12F3N4.C10H13N4.C8H9N4.3Pt/c1-10-9-12(16-15-10)13-14-7-8-17(13)11-5-3-2-4-6-11;3*1-11(2,3)7-4-5-16-8(6-7)9-17-10(19-18-9)12(13,14)15;1-7(2)14-5-4-11-10(14)9-6-8(3)12-13-9;1-6-5-7(11-10-6)8-9-3-4-12(8)2;;;/h2-9H,1H3;3*4-6H,1-3H3;4-7H,1-3H3;3-5H,1-2H3;;;/q6*-1;3*+2
InChIKeyAKSIWJSVKVAYLS-UHFFFAOYSA-N
MW1966.67 g/mol
LogP13.17
Rot. Bonds8

About tris(4-tert-butyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine);3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+))

tris(4-tert-butyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine);3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+)) (PubChem CID 157146122) has the molecular formula C67H69F9N24Pt3 and a molecular weight of 1966.67 g/mol. Its IUPAC name is tris(4-tert-butyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine);3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+)).

Molecular Properties

Compound Nametris(4-tert-butyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine);3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+))
PubChem CID157146122
Molecular FormulaC67H69F9N24Pt3
Molecular Weight1966.67 g/mol
Exact Mass1965.49
IUPAC Nametris(4-tert-butyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine);3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+))
SMILESCC(C)(C)c1ccnc(-c2nc(C(F)(F)F)n[n-]2)c1.CC(C)(C)c1ccnc(-c2nc(C(F)(F)F)n[n-]2)c1.CC(C)(C)c1ccnc(-c2nc(C(F)(F)F)n[n-]2)c1.Cc1cc(-c2nccn2-c2ccccc2)[n-]n1.Cc1cc(-c2nccn2C(C)C)[n-]n1.Cc1cc(-c2nccn2C)[n-]n1.[Pt+2].[Pt+2].[Pt+2]
InChIInChI=1S/C13H11N4.3C12H12F3N4.C10H13N4.C8H9N4.3Pt/c1-10-9-12(16-15-10)13-14-7-8-17(13)11-5-3-2-4-6-11;3*1-11(2,3)7-4-5-16-8(6-7)9-17-10(19-18-9)12(13,14)15;1-7(2)14-5-4-11-10(14)9-6-8(3)12-13-9;1-6-5-7(11-10-6)8-9-3-4-12(8)2;;;/h2-9H,1H3;3*4-6H,1-3H3;4-7H,1-3H3;3-5H,1-2H3;;;/q6*-1;3*+2
InChIKeyAKSIWJSVKVAYLS-UHFFFAOYSA-N
XLogP13.17
TPSA292.74 Ų
H-Bond Donors
H-Bond Acceptors18
Rotatable Bonds8
Heavy Atoms103
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001966.67
LogP ≤ 513.17
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1018

Analyze tris(4-tert-butyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine);3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+)) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[[4-[[2-(2-Fluorophenyl)imidazo[4,5-c]pyridin-5-yl]methyl]triazol-1-yl]methyl]-5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine
CID 145968901
Platinum(2+);3-(1-propan-2-ylimidazol-2-yl)-5-(trifluoromethyl)pyrazol-1-ide;2-[5-(trifluoromethyl)pyrazol-1-id-3-yl]pyridine
CID 168346600
1-(2-Fluorobenzyl)-3-[5-(5-isopropyl-2,5-diazabicyclo[2.2.1]hept-2-yl)-2-pyrimidinyl]-1h-pyrazol[3,4-b]pyridine
CID 21983518
3-[5-(5,5-Dimethyl-2-aza-5-azoniabicyclo[2.2.1]heptan-2-yl)pyrimidin-2-yl]-1-[(2-fluorophenyl)methyl]pyrazolo[5,4-b]pyridine
CID 21983545
1-[(2-Fluorophenyl)methyl]-3-[5-(5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidin-2-yl]pyrazolo[5,4-b]pyridine
CID 23548203
2-[2-[1-[(2-fluorophenyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]pyrimidin-5-yl]-3,3a,5,6,7,7a,8,8a-octahydro-1H-pyrrolo[3,4-b]pyrrolizine
CID 23548215
2-(2,4-Difluorobenzene-6-id-1-yl)pyridine;iridium;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide
CID 57668487
4-(4-Tert-butylphenyl)-3-methyl-5-phenyl-1,2,4-triazole;iridium;2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine
CID 58426431
1-[(5-Fluoro-2-methylbenzene-6-id-1-yl)methyl]pyrazole;1-[[5-fluoro-2-(trifluoromethyl)benzene-6-id-1-yl]methyl]pyrazole;iridium(3+);2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine
CID 58567818
4-Tert-butyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;1-[(2,4-difluorobenzene-6-id-1-yl)methyl]-2-methanidylpyrazol-2-ium;1-[(2,4-difluorobenzene-6-id-1-yl)methyl]pyrazole;iridium
CID 58567840
3,5-Dimethyl-1-phenylpyrazole;3,5-dimethyl-2-phenylpyrazol-2-ium-1-ide;iridium;2-[5-[4-(trifluoromethyl)phenyl]-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine
CID 58855106
Iridium;1-phenylpyrazole;2-phenylpyrazol-2-ium-1-ide;2-[5-[4-(trifluoromethyl)phenyl]-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine
CID 58855107

Frequently Asked Questions

What is the IUPAC name of tris(4-tert-butyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine);3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+))?
The IUPAC name of tris(4-tert-butyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine);3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+)) (CID 157146122) is tris(4-tert-butyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine);3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+)).
What is the SMILES notation for tris(4-tert-butyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine);3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+))?
The canonical SMILES for tris(4-tert-butyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine);3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+)) is CC(C)(C)c1ccnc(-c2nc(C(F)(F)F)n[n-]2)c1.CC(C)(C)c1ccnc(-c2nc(C(F)(F)F)n[n-]2)c1.CC(C)(C)c1ccnc(-c2nc(C(F)(F)F)n[n-]2)c1.Cc1cc(-c2nccn2-c2ccccc2)[n-]n1.Cc1cc(-c2nccn2C(C)C)[n-]n1.Cc1cc(-c2nccn2C)[n-]n1.[Pt+2].[Pt+2].[Pt+2].
What is the InChIKey of tris(4-tert-butyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine);3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+))?
The InChIKey is AKSIWJSVKVAYLS-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H11N4.3C12H12F3N4.C10H13N4.C8H9N4.3Pt/c1-10-9-12(16-15-10)13-14-7-8-17(13)11-5-3-2-4-6-11;3*1-11(2,3)7-4-5-16-8(6-7)9-17-10(19-18-9)12(13,14)15;1-7(2)14-5-4-11-10(14)9-6-8(3)12-13-9;1-6-5-7(11-10-6)8-9-3-4-12(8)2;;;/h2-9H,1H3;3*4-6H,1-3H3;4-7H,1-3H3;3-5H,1-2H3;;;/q6*-1;3*+2.
What are the key properties of tris(4-tert-butyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine);3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+))?
tris(4-tert-butyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine);3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+)) has a molecular weight of 1966.67 g/mol, XLogP of 13.17, 8 rotatable bonds, 0 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for tris(4-tert-butyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine);3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+)) is sourced from PubChem (CID 157146122), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).